In contrast, none of EA80 VUS targeted phosphorylation sites of RPA (N-terminal of RPA2) (Marechal and Zou, 2015), critical for DNA damage response and indicator of cancer progression: this implies that phosphorylation regulation is critical for cancer development and viability (Rector et al., 2017). This evidence concerns the gene RPA2 and cancer.